Sugammadex is a novel pharmacologic agent, which reverses neuromuscular blockade with
a mechanism that differs from the commonly used, acetylcholinesterase inhibitors. Although …

Background and Objectives: Sugammadex is widely used in anesthesia to reverse
rocuronium-induced neuromuscular blockade (NMB). In patients with compromised kidney …

• Appropriate reversal of a nondepolarizing neuromuscular blockade is essential to avoid
adverse patient outcomes. Complete recovery of muscle strength should be present, and the …

Background Simultaneous pancreas-kidney transplantation (SPK) is a time-consuming and
important surgical procedure, which can provide a physiological mean of achieving …

Living‐donor kidney transplantation is the first choice therapy for children with end‐stage
renal disease and shows good long‐term outcome. Etiology of renal failure, co‐morbidities …

Sugammadex (SUG) is a novel antagonist of neuromuscular blocking agents (NMBAs). The
NMBA rocuronium is usually employed to obtain better surgical conditions in kidney …

Sugammadex is a novel pharmacologic agent, which reverses neuromuscular blockade with
a mechanism that differs from acetylcholinesterase inhibitors such as neostigmine. There is …

Introduction Sugammadex has the steroid-encapsulating effect that reverses neuromuscular
block induced by aminosteroid neuromuscular-blocking agents. Sugammadex can interact …

Abstract Study Objective To evaluate the efficacy and safety of sugammadex in reversing
profound neuromuscular block induced by rocuronium in infant patients. Design …

Background Rocuronium can be used in patients with severe renal failure (creatinine
clearance< 30 mL/min), but the duration of muscle relaxation is longer and results in an …